Literature DB >> 14762858

E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation.

Michael G Hughes1, Christine K Rudy, Tae W Chong, Robert L Smith, Heather L Evans, Julia C Iezzoni, Robert G Sawyer, Timothy L Pruett.   

Abstract

It is unknown whether all hepatitis C virus (HCV) quasispecies variants found within patient serum have equal capacity to associate with the liver after transplantation; however, in vitro models of HCV infection suggest that variations in the hypervariable region 1 (HVR1) of the second envelope protein (E2) may be important in infectivity. The hypothesis of the current study is that the two hypervariable regions (HVR1 and HVR2) within E2 are important in the initial virus-liver interaction, and, therefore, certain HCV quasispecies variants will be isolated from the liver after reperfusion. In 8 patients with end-stage liver disease secondary to HCV infection, HCV envelope quasispecies were determined from intraoperative serum samples obtained before the anhepatic phase of transplantation and from liver biopsies 1.5 to 2.5 hours after the transplanted liver was perfused. Explanted (native) liver biopsies were taken as a control. Sequence analysis was performed on clones of specific HCV reverse transcriptase-polymerase chain reaction products spanning HVR1 and HVR2 of the E2 protein. HVR1 was more variable than HVR2 for all samples. Quasispecies isolated from postperfusion liver differed more from serum than did explanted liver quasispecies at HVR1 (P = 0.03) but not at HVR2 (P = 0.2). Comparison of HVR1 sequences from postperfusion liver versus serum revealed significantly less HVR1 genetic complexity and diversity (P = 0.02 and P = 0.04, respectively). Immediately after transplantation but before actual infection, liver allografts select out from the infecting serum inoculum a less heterogeneous, more closely related population of quasispecies variants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762858     DOI: 10.1002/lt.20060

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.

Authors:  Zhi Qiang Yao; Stephen N Waggoner; Michael W Cruise; Caroline Hall; Xuefang Xie; David W Oldach; Young S Hahn
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Unexpected maintenance of hepatitis C viral diversity following liver transplantation.

Authors:  Rebecca R Gray; Samantha L Strickland; Nazle M Veras; Maureen M Goodenow; Oliver G Pybus; Stanley M Lemon; Michael W Fried; David R Nelson; Marco Salemi
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Antithymocyte globulin induction therapy in hepatitis C-positive liver transplant recipients.

Authors:  Peter J Horton; Jean Tchervenkov; Jeff S Barkun; Caroline Rochon; Prosanto K Chaudhury; Tammy L Znajda; John B Martinie; Peter Metrakos
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

Review 4.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.

Authors:  Hui Li; Daniel G Sullivan; Nathan Feuerborn; Susan McArdle; Kirubeal Bekele; Sampa Pal; Matthew Yeh; Robert L Carithers; James D Perkins; David R Gretch
Journal:  Virology       Date:  2010-04-18       Impact factor: 3.616

Review 6.  Human liver transplantation as a model to study hepatitis C virus pathogenesis.

Authors:  Michael G Hughes; Hugo R Rosen
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

7.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

8.  HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.

Authors:  Giovanna Russelli; Paola Pizzillo; Gioacchin Iannolo; Floriana Barbera; Fabio Tuzzolino; Rosa Liotta; Mario Traina; Giovanni Vizzini; Bruno Gridelli; Ester Badami; Pier Giulio Conaldi
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

9.  Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.

Authors:  Michael G Hughes; William W Tucker; Sreelatha Reddy; Michael E Brier; David Koch; Craig J McClain; Colleen B Jonsson; Nobuyuki Matoba; Donghoon Chung
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.